Series C - Genomics

Series C - Genomics

Investment Firm

Overview

Genomics plc aiming to lead the genomic transformation of healthcare.

Announced Date

Jan 08, 2024

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

F-Prime Capital

F-Prime Capital

F-Prime Capital is a early_stage_venture and late_stage_venture and seed and venture firm.

Foresite Capital

Foresite Capital

Foresite Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

4

Investor Name
Participant InvestorInfinity Investment Partners
Participant InvestorMassMutual
Participant InvestorForesite Capital
Participant InvestorF-Prime Capital

Round Details and Background

Genomics raised $44596554 on 2024-01-08 in Series C

Genomics plc aiming to lead the genomic transformation of healthcare.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2021
Venture Round - Genomics
4-30.0M
Jan 18, 2021
Secondary Market - Genomics
1-undefined
Jan 08, 2024
Series C - Genomics
4-44.6M
Nov 26, 2014
Series A - Genomics
5-16.2M

Recent Activity

There is no recent news or activity for this profile.